lead position
Sponsored content
Sponsored by
CCPIT Patent and Trademark Law Office
Features list
-
Robert Reading of CompuMark examines some of the common perceptions of pharmaceutical trademarks and how they measure up in reality
-
Masato Iida of Shiga examines examples of patent claims related to antibody drugs, assessing which data is included in claims
-
Erick Robinson of Dunlap, Bennett & Ludwig examines three underused patent strategies for companies, including those in the US, to succeed in China
-
Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption
-
Cristina Biggi of Bugnion examines the introduction of the new SPC manufacturing waiver, including the process that led to its creation and the amendments it makes to the SPC regulation
-
Following the UK’s introduction of a doctrine of equivalents, Paul England of Taylor Wessing looks at the potential application of aspects of German IP law to determine the breadth of the doctrine’s scope
Local Insights